Tempo Therapeutics, Inc.

New Filing

CIK: 0001813688·Biotechnology·DELAWARE·Filed: Sep 11, 2026

Total Offering

$14,500,000

Amount Sold

$14,000,000

Investors

43

First Sale

Aug 27, 2026

Offering Details

Type: Debt
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Westbrook Weaver
Donald Griffin
Biren Mehta
Steven Sands
Eric Richman

Company

Tempo Therapeutics, Inc.

3030 BUNKER HILL STREET

SAN DIEGO, CA, 92109

6192027445

SEC Filing

0001813688-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.